These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37303296)

  • 1. The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression.
    Cabrerizo Granados D; Barbosa I; Baliakas P; Hellström-Lindberg E; Lundin V
    Genes Chromosomes Cancer; 2023 Nov; 62(11):672-677. PubMed ID: 37303296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.
    Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
    Blood Adv; 2024 Jan; 8(2):497-511. PubMed ID: 38019014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Marrow Morphology Associated With Germline
    Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
    Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
    Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
    Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
    Schlegelberger B; Heller PG
    Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree].
    Guan J; Wang LL; Wang CY; Zhu XM; Shuai HZ; Yi X; Zou L; Yu D; Cheng H
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):393-400. PubMed ID: 37032134
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic Landscape of Patients with Germline
    Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
    bioRxiv; 2023 Jan; ():. PubMed ID: 36789433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive phenotypes in two children with novel germline
    Bagla S; Regling KA; Wakeling EN; Gadgeel M; Buck S; Zaidi AU; Flore LA; Chicka M; Schiffer CA; Chitlur MB; Ravindranath Y
    Pediatr Hematol Oncol; 2021 Feb; 38(1):65-79. PubMed ID: 32990483
    [No Abstract]   [Full Text] [Related]  

  • 9. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
    Simon L; Spinella JF; Yao CY; Lavallée VP; Boivin I; Boucher G; Audemard E; Bordeleau ME; Lemieux S; Hébert J; Sauvageau G
    Blood; 2020 May; 135(21):1882-1886. PubMed ID: 32315381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial platelet disorder due to germline exonic deletions in
    Engvall M; Karlsson Y; Kuchinskaya E; Jörnegren Å; Mathot L; Pandzic T; Palle J; Ljungström V; Cavelier L; Hellström Lindberg E; Cammenga J; Baliakas P
    Leuk Lymphoma; 2022 Oct; 63(10):2311-2320. PubMed ID: 35533071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.
    Brown AL; Arts P; Carmichael CL; Babic M; Dobbins J; Chong CE; Schreiber AW; Feng J; Phillips K; Wang PPS; Ha T; Homan CC; King-Smith SL; Rawlings L; Vakulin C; Dubowsky A; Burdett J; Moore S; McKavanagh G; Henry D; Wells A; Mercorella B; Nicola M; Suttle J; Wilkins E; Li XC; Michaud J; Brautigan P; Cannon P; Altree M; Jaensch L; Fine M; Butcher C; D'Andrea RJ; Lewis ID; Hiwase DK; Papaemmanuil E; Horwitz MS; Natsoulis G; Rienhoff HY; Patton N; Mapp S; Susman R; Morgan S; Cooney J; Currie M; Popat U; Bochtler T; Izraeli S; Bradstock K; Godley LA; Krämer A; Fröhling S; Wei AH; Forsyth C; Mar Fan H; Poplawski NK; Hahn CN; Scott HS
    Blood Adv; 2020 Mar; 4(6):1131-1144. PubMed ID: 32208489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
    Yokota A; Huo L; Lan F; Wu J; Huang G
    Mol Cells; 2020 Feb; 43(2):145-152. PubMed ID: 31964134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
    Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
    Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A
    Wang CP; Ferreira JE; Placek A; Aguayo-Hiraldo P; Raca G; Wood BL; Miller KP; Coates T; Freyer DR; Kovach AE
    Leuk Lymphoma; 2024 Sep; 65(9):1357-1361. PubMed ID: 38733629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
    Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
    J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
    Hyde RK; Liu P; Friedman AD
    Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
    Harada Y; Harada H
    J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
    Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
    Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.